Wedmont Private Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $787K | Sell |
11,291
-18
| -0.2% | -$1.25K | 0.03% | 320 |
|
|
2025
Q1 | $732K | Sell |
11,309
-141
| -1% | -$9.13K | 0.04% | 282 |
|
|
2024
Q4 | $988K | Buy |
11,450
+330
| +3% | +$28.5K | 0.05% | 222 |
|
|
2024
Q3 | $1.31M | Buy |
11,120
+809
| +8% | +$95.3K | 0.07% | 167 |
|
|
2024
Q2 | $1.46M | Buy |
10,311
+1,224
| +13% | +$174K | 0.09% | 137 |
|
|
2024
Q1 | $1.13M | Buy |
9,087
+236
| +3% | +$29.5K | 0.08% | 164 |
|
|
2023
Q4 | $942K | Buy |
8,851
+2,992
| +51% | +$318K | 0.08% | 177 |
|
|
2023
Q3 | $539K | Buy |
5,859
+1,255
| +27% | +$116K | 0.05% | 238 |
|
|
2023
Q2 | $369K | Sell |
4,604
-10
| -0.2% | -$801 | 0.04% | 330 |
|
|
2023
Q1 | $367K | Buy |
4,614
+322
| +8% | +$25.6K | 0.05% | 286 |
|
|
2022
Q4 | $298K | Buy |
4,292
+108
| +3% | +$7.49K | 0.04% | 336 |
|
|
2022
Q3 | $208K | Buy |
4,184
+430
| +11% | +$21.4K | 0.04% | 351 |
|
|
2022
Q2 | $209K | Buy |
+3,754
| New | +$209K | 0.05% | 311 |
|